These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38545625)
1. Newborn screening for Duchenne muscular dystrophy: the perspectives of stakeholders. Ji C; Kariyawasam DS; Sampaio H; Lorentzos M; Jones KJ; Farrar MA Lancet Reg Health West Pac; 2024 Apr; 45():101049. PubMed ID: 38545625 [TBL] [Abstract][Full Text] [Related]
2. Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy. Farrar MA; Kariyawasam D; Grattan S; Bayley K; Davis M; Holland S; Waddel LB; Jones K; Lorentzos M; Ravine A; Wotton T; Wiley V; J Neuromuscul Dis; 2023; 10(1):15-28. PubMed ID: 36373292 [TBL] [Abstract][Full Text] [Related]
3. A qualitative exploration of the priorities and experiences of children with Duchenne muscular dystrophy, their parents, and healthcare professionals around weight management. Walker M; Mistry B; Amin R; McAdam L; Kalnins D; Lui T; McPherson AC Disabil Rehabil; 2022 Dec; 44(26):8234-8242. PubMed ID: 34889714 [TBL] [Abstract][Full Text] [Related]
4. The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report. Armstrong N; Apkon S; Berggren KN; Braun C; Ciafaloni E; Connolly A; Kennedy A; Kuntz N; Mathews K; McGuire M; Parad R; Scavina M; Scharf RJ; Waldrop M J Neuromuscul Dis; 2024; 11(2):525-533. PubMed ID: 38189762 [TBL] [Abstract][Full Text] [Related]
5. Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care. Armstrong N; Schrader R; Fischer R; Crossnohere N Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):162-168. PubMed ID: 35932090 [TBL] [Abstract][Full Text] [Related]
7. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991 [TBL] [Abstract][Full Text] [Related]
8. Patient engagement in clinical trial design for rare neuromuscular disorders: impact on the DELIVER and ACHIEVE clinical trials. Furlong P; Dugar A; White M Res Involv Engagem; 2024 Jan; 10(1):1. PubMed ID: 38167117 [TBL] [Abstract][Full Text] [Related]
10. Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot. Hartnett MJ; Lloyd-Puryear MA; Tavakoli NP; Wynn J; Koval-Burt CL; Gruber D; Trotter T; Caggana M; Chung WK; Armstrong N; Brower AM Int J Neonatal Screen; 2022 Sep; 8(4):. PubMed ID: 36278620 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed-methods study. Crossnohere NL; Armstrong N; Fischer R; Bridges JFP Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):169-177. PubMed ID: 35943031 [TBL] [Abstract][Full Text] [Related]
12. Twenty-year follow-up of newborn screening for patients with muscular dystrophy. Chung J; Smith AL; Hughes SC; Niizawa G; Abdel-Hamid HZ; Naylor EW; Hughes T; Clemens PR Muscle Nerve; 2016 Apr; 53(4):570-8. PubMed ID: 26260293 [TBL] [Abstract][Full Text] [Related]
13. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study. Tavakoli NP; Gruber D; Armstrong N; Chung WK; Maloney B; Park S; Wynn J; Koval-Burt C; Verdade L; Tegay DH; Cohen LL; Shapiro N; Kennedy A; Noritz G; Ciafaloni E; Weinberger B; Ellington M; Schleien C; Spinazzola R; Sood S; Brower A; Lloyd-Puryear M; Caggana M; Ann Clin Transl Neurol; 2023 Aug; 10(8):1383-1396. PubMed ID: 37350320 [TBL] [Abstract][Full Text] [Related]
14. Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption. Parad RB; Sheldon Y; Bhattacharjee A Int J Neonatal Screen; 2021 Nov; 7(4):. PubMed ID: 34842620 [TBL] [Abstract][Full Text] [Related]
16. Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy. Gruber D; Lloyd-Puryear M; Armstrong N; Scavina M; Tavakoli NP; Brower AM; Caggana M; Chung WK Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):197-205. PubMed ID: 36152336 [TBL] [Abstract][Full Text] [Related]
17. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy. Ross LF Am J Med Genet A; 2006 Apr; 140(8):914-22. PubMed ID: 16528755 [TBL] [Abstract][Full Text] [Related]
18. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan. Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557 [TBL] [Abstract][Full Text] [Related]
19. Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment. Ke Q; Zhao ZY; Griggs R; Wiley V; Connolly A; Kwon J; Qi M; Sheehan D; Ciafaloni E; Howell RR; Furu P; Sazani P; Narayana A; Gatheridge M World J Pediatr; 2017 Jun; 13(3):197-201. PubMed ID: 28466241 [TBL] [Abstract][Full Text] [Related]